ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LUIS BIELER MD

Internal Medicine

16,564

$933K

634
460 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

JOSEFA SANTIAGO MD

Internal Medicine

16,554

$924K

526
406 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

WILLIAM GONZABA M.D.

Internal Medicine

16,505

$1.11M

1313
956 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $67

VERNE WILLITS M.D.

Internal Medicine

16,494

$794K

645
497 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $67

OMAR GOMEZ MD

Internal Medicine

16,421

$1.3M

810
644 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $67

ANGELES LAI ZAYAS M.D.

Internal Medicine

16,376

$960K

801
678 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

HUGO ROJAS MD, PA

Internal Medicine

16,362

$1.17M

805
318 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $67

JOSEPH MAROTTA M.D.

Internal Medicine

16,360

$1.17M

496
294 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

44%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $67

KIMBERLY BARBOLLA DO

Internal Medicine

16,353

$1.1M

503
391 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $67

GRACIELA LEIJA MD

Internal Medicine

16,259

$692K

629
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $67

MARK BLICK D.O.

Internal Medicine

16,149

$1.18M

809
676 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

DANNEY DREWRY D.O

Internal Medicine

16,066

$1.03M

669
568 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

ANTHONY GAMBRAH MD. FACP

Internal Medicine

16,054

$845K

495
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

NAILA RAMIZ M.D.

Internal Medicine

16,039

$1.09M

636
462 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $67

JASON LEDBETTER M.D.

Internal Medicine

15,996

$815K

673
608 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

SAM THOYAKULATHU MD

Internal Medicine

15,978

$835K

435
331 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

ELEANORA DUKE M.D.

Internal Medicine

15,976

$863K

719
563 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

RADAMES RODRIGUEZ MD

Internal Medicine

15,920

$882K

895
556 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

LAWRENCE ROE M.D.

Internal Medicine

15,850

$769K

746
694 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

WAYNE KARAKI MD

Internal Medicine

15,825

$1.16M

887
565 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

KENNETH FLORY M.D.

Internal Medicine

15,806

$621K

487
414 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$39
Average prescription price

Avg: $67

PRABHUGOUDA PATIL MD

Internal Medicine

15,768

$983K

592
385 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

37%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

MANAVALAN SINGAPERUMAL MD

Internal Medicine

15,760

$809K

564
460 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

TODD NGUYEN M.D.

Internal Medicine

15,549

$1.08M

698
445 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

MSONTHI LEVINE MD

Internal Medicine

15,488

$1.07M

848
561 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank